Millipore Sigma Vibrant Logo

ABS1079 Anti-UBE4B Antibody

View Products on Sigmaaldrich.com
ABS1079
100 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Fulfillment and delivery delayed
Fulfillment and delivery delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWB, ICCRbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue NumberABS1079
      DescriptionAnti-UBE4B Antibody
      Alternate Names
      • Ubiquitin conjugation factor E4 B
      • Homozygously deleted in neuroblastoma 1
      • Ubiquitin fusion degradation protein 2
      • UBE4B
      Background InformationUbiquitin conjugation factor E4 B (UniProt O95155; also known as Homologous to yeast UFD2, Homozygously deleted in neuroblastoma 1, Ubiquitin fusion degradation protein 2) is encoded by the UBE4B (also known as E4, HDNB1, UBOX3, UFD2, UFD2A) gene (Gene ID 10277) in human. The turnover of plasma membrane proteins involves internalization and sorting by the endocytic pathway. Ubiquitin modification allows proteins to be recognized by endosomally associated protein complexes, enabling sorting of proteins to be degraded from those to be recycled. The ubiquitin ligase UBE4B is reported to interact with "hepatocyte growth factor-regulated tyrosine kinase substrate" (Hrs) of the "endosomal sorting complex required for transport 0" (ESCRT-0) complex at the endosomal membrane, where UBE4B ubiquitinates internalized EGFR to allow its recognition by ESCRT-0. The deubiquinating enzyme USP8 then associates with ESCRT-0 via binding to "signal-transducing adaptor molecule" (STAM), while UBE4B dissociates from ESCRT-0. ESCRT-I and II then bind to cargo and facilitate membrane budding inward toward the lumen, whereas ESCRT-III mediates the dissociation of ESCRTs from endosomal membranes and membrane scission.
      References
      Product Information
      FormatAffinity Purified
      PresentationPurified rabbit polyclonal antibody in buffer containing Tris-HCl with 0.05% sodium azide with 50% glycerol.
      Quality LevelMQ100
      Applications
      ApplicationDetect UBE4B using this rabbit Polyclonal Anti-UBE4B Antibody, Cat. No. ABS1079, validated for use in Western Blotting and ICC.
      Key Applications
      • Western Blotting
      • Immunocytochemistry
      Application NotesWestern Blotting Analysis: A representative lot detected recombinant UBE4B, endogenous UBE4B in STAM immunoprecipitate from HeLa cells, and siRNA-mediated UBE4B depletion in HeLa cells (Sirisaengtaksin, N., et al. (2014). J Biol Chem. 289(5):3026-3039).
      Immunocytochemistry Analysis: A representative lot detected UBE4B cellular localization in HeLa cells with or without EGF-EGFR internalization (Sirisaengtaksin, N., et al. (2014). J Biol Chem. 289(5):3026-3039).
      Biological Information
      ImmunogenRecombinant protein corresponding to human UBE4B.
      ConcentrationPlease refer to lot specific datasheet.
      HostRabbit
      SpecificityThis antibody is expected to react with all 4 spliced isoforms of human UBE4B protein.
      Species Reactivity
      • Human
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • UBE4B
      • HDNB1
      • KIAA0684
      • UFD2
      Purification MethodAffinity Purfied
      UniProt Number
      Molecular Weight~130 kDa observed
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in K562 cell lysate.

      Western Blotting Analysis: A 1:5,000 dilution of this antibody detected UBE4B in 10 µg of K562 cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      ABS1079 04055977176520

      Documentation

      Anti-UBE4B Antibody SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-UBE4B Antibody Certificates of Analysis

      TitleLot Number
      Anti-UBE4B -Q2581248 Q2581248

      References

      Reference overviewPub Med ID
      UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation.
      Sirisaengtaksin, N; Gireud, M; Yan, Q; Kubota, Y; Meza, D; Waymire, JC; Zage, PE; Bean, AJ
      The Journal of biological chemistry  289  3026-39  2014

      Show Abstract
      24344129 24344129

      Technical Info

      Title
      Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System
      White Paper: Further considerations of antibody validation and usage.